{"name":"Blood Cancer United","slug":"blood-cancer-united","ticker":"","exchange":"","domain":"","description":"Blood Cancer United, a 501(c)(3) charitable organization founded in 1949, is a voluntary health organization dedicated to fighting blood cancer world-wide. Blood Cancer United funds blood cancer research to develop cures for all types of blood cancer, including Hodgkin's disease, Leukemia, Lymphoma, Myelodysplastic syndrome, Myeloma, and Myeloproliferative neoplasm. Formerly known as the Leukemia & Lymphoma Society, the organization provides free information and support services, and it advocates for blood cancer patients and their families seeking access to quality and affordable care.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Amended LLS COVID-19 Registry","genericName":"Amended LLS COVID-19 Registry","slug":"amended-lls-covid-19-registry","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Amended LLS COVID-19 Registry","genericName":"Amended LLS COVID-19 Registry","slug":"amended-lls-covid-19-registry","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBDYkZNbUNSakJSUkl0dG92YnczZ01DUW1mY2Qxb2d3THphYmE2QkxxQXhpWk5YTDFnMFJ3OFpmSkVmOE9PTE9XMUxYaU4wclp1T01GOFBvcG51ZWVhR2plNmFqYjdfUFFGdHh6MDln0gFyQVVfeXFMTnhwS2hmMHRtZWthdDdpZWp2WVNsSElwelZHSjkzUWRjc3MtNkF2Um9admhDUHh6NWwwLW9mTGNrX1ktM2FzeXVQU25zdjV3OGYyTXZCeWV6QTJ2TERaaXBJaVJ3cDgwMEVLZk9INWhsUGd3?oc=5","date":"2026-04-07","type":"pipeline","source":"koreabiomed.com","summary":"Truxima leads US rituximab prescriptions, Celltrion says - koreabiomed.com","headline":"Truxima leads US rituximab prescriptions, Celltrion says","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPTTRkMHJiRnRJY2hIa09KTEVRZURZN0UwcjBzTC1JeDl3anlxRmZ1d3pLRm9jM21MUk5uY21ocUJXWXo4aFZiV0h0bi1oMWxVN28tdFY2VERMNVkxNFJ3ZTVKM1J3ZVk5eDZUWlk0eC1OU0M4ZnJfbWtSUnRBemVuanZmSkNwM0JUYk1USXJQdndlZjVuZ3lXcjg0QXRSU0ZRSWhrLXpLc2hJeXgzX2J6N3dKWnRmb25Ic0JUOGRIUmhpRUl1YTVGV1BzUGc4TlRFeHdXQlpDTVpaa0NpTEVsd2NxcHJJNURjdlE?oc=5","date":"2026-03-18","type":"pipeline","source":"Pharmaceutical Executive","summary":"Pharma Funding Roundup: Excalipoint Therapeutics Completes $68.7 Million Seed Finance Round, Crossbow Therapeutics Raises $77 Million in Series B Financing - Pharmaceutical Executive","headline":"Pharma Funding Roundup: Excalipoint Therapeutics Completes $68.7 Million Seed Finance Round, Crossbow Therapeutics Raise","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-03","type":"patent","source":"ET Pharma","summary":"Lupin launches blood cancer generic in US - ET Pharma","headline":"Lupin launches blood cancer generic in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHNxeFlMbmszZFNqc29NZmhWTGZjZDJrZ0JMX0haTkpiSjlhUUJSZWt1d0llRU9WX01rYmVGdW04MEJXX2tDNXVYdUNULVhSbjlUNzRNMkdya0FSOUVQY0hJZ3llYzV2U2tqeThVZGJWdXJGLWM1MEpibWZYZF9BeVNMYjRRX2tGSUo1UGh4SW4tQQ?oc=5","date":"2026-01-16","type":"deal","source":"NPR","summary":"Trump struck deals with 16 drug companies. But they're still raising prices this year - NPR","headline":"Trump struck deals with 16 drug companies. But they're still raising prices this year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNVWJ5cUV2MXl3UGx0VE9GRDYyT2lobjlJQlFTdHh5Ym9zN1RuWE1TcnE2TEhPTHpqbHFUeGFNVTkyemtmdWRUZnlHMVNkUVJ6Y2w1OUZTdFV3WndTanM4YURTTjd1VkNiRDFaLXRmT2thdkdEejVPS2M0a0oySm81WHVlWVluSlNnMUZleTlraHpQelJGZlFra29MU0dhdk9FWTNLZzl0clZTcDFVQUVRQWZ5SEhCclUtNXVzQWtacFQxeFY3MVFmdC1kMVREMGh3aXNfYVRWYzd0SjRoeVVBQWluQzhRVjBhdFE?oc=5","date":"2026-01-14","type":"trial","source":"PR Newswire","summary":"Blood Cancer United Expands its Beat AML® Master Clinical Trial Advancing Next-Generation Treatment - PR Newswire","headline":"Blood Cancer United Expands its Beat AML® Master Clinical Trial Advancing Next-Generation Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOZ1AtRnRGeXB4WmpmVFZwcHZ6czc2UjlmVW05TFEzRU9FTnNia0V4QmpLWWpvT2JiTV9BNmIyelBjQzVGTUtaMDl6ZFZzOERwYlBjanZERVFmWUlMTU52MGRBU0lzcUdzUVpCNWxFNnpyRElwRUtCLTE3YXNtRDZLR3RVMVZCNlNqYTlnMFJBbEM?oc=5","date":"2025-12-06","type":"regulatory","source":"statnews.com","summary":"‘Remarkable’ drug results against an aggressive leukemia - statnews.com","headline":"‘Remarkable’ drug results against an aggressive leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxOYVRpMmJodUZVUjNhYnhkNXhBekNKWThXZzZwVHp0Ym9JYlJPbmV4Zzl6RWw0d2d5WTBBbGhMbGIwaGtPSGZqMUZpY1BqRWVRSjhseVE1M1RibkRFTGJKN3B1WnJhUGlTQWFIb1QwSW5VS3BxbGxnZFFSNk1wbXE1V0s2dDdPQm8wNmpXLWNSc1R5OEppd0RBUTByV0ZrekpGZ3g2M2xuUEdOTGpVSGxGYk5aNXlCOWtleWdDdlFFMFlhV3g0RThRdm9HRllST3Zhdkh6elY4eTVLeGZkWVJ2b2prYlF6T2tXY3FITDlB?oc=5","date":"2025-11-21","type":"regulatory","source":"UConn Today","summary":"FDA Recall of Blood Pressure Pills Due to Cancer-Causing Contaminant May Point to Higher Safety Risks in Older Generic Drugs - UConn Today","headline":"FDA Recall of Blood Pressure Pills Due to Cancer-Causing Contaminant May Point to Higher Safety Risks in Older Generic D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOV19zSV9vRHpaNHM0MHFBeWRaYnZCZTlRbE11MEZPaUVjRHNMWkNidjg3NkYtZFJvWWRmcElXWXNMRW1UbHlRcU05bl84QjZmNVYtT29iLWc0Vy0ta2hNbS1sbUFWaHZDeXZMV1FOTkhKNUdjTWR2NHRjdmE3R2VaTW1jajd5WlA4cUN3ME5FQ3psQzBrT0hrajd1NWM3bWZMX3lzaU1GTGpMTDBNZDNKUWFXeXloVklsdWNjMUUzd3FRdF90NlhLekFYTUdUNTM4TmpnOEJzRQ?oc=5","date":"2025-10-24","type":"regulatory","source":"Reuters","summary":"GSK shares fall as narrow approval of blood cancer drug limits US relaunch - Reuters","headline":"GSK shares fall as narrow approval of blood cancer drug limits US relaunch","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQc0Q3RUdhOEZsNUVCUTI2cEFGZkFkZ2JSWmM2dEZrV2ZGbGxZelBsWEswbF81em94ajhMQlQ2WHVzVmdzNl9SN0k1d1Z6M2xiTkRWTF8tRkRtSGM2bVZrbktSR0kzeUtJdDQ3R1E2QmdMOWhUdkxlTWtrUW1hU0RFWm5FWWZOYnFFRllLVEl3MnBuR29xcE83QVRfa29XNnh5ZHE4MVUxc0NMU0NXdkhKSUt5RkZEdnVQQjN6OFJQUHU0MU0?oc=5","date":"2025-10-09","type":"pipeline","source":"KSAT","summary":"How Blood Cancer United helps patients gain access to affordable cancer treatment - KSAT","headline":"How Blood Cancer United helps patients gain access to affordable cancer treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPUm9qbFNrM1p4SkJnNlF6czhEUlZ5c2hNZTRCWVpsWEt1QnVkaW5MM3hpUU1yZEVPcVgyV0J6SEVTci0tbGJwOHAxUGRPSVdTSWRES0hJTVNXMGp4U25ialk1RHhvODJrVHdsb18yaDRHem5kNkkzU18wb0FyX0ZEZkxSRS1RYlJnT1U0VmI1MXNSR2dtM2hvdzEwRFkyR1NoX1U4VnU1RzdORE82REU3eXBUSzhyemh5Z2syczJFV203ZHZUa0JhR19Lcnc3LXpTQnE3aW4zQ3c1bmNyTEV4X0RsbVZoeDFMUU04?oc=5","date":"2025-09-23","type":"pipeline","source":"PR Newswire","summary":"Blood Cancer United Responds to Federal Funding Crisis with $8 Million Gift from Big Nova Foundation - PR Newswire","headline":"Blood Cancer United Responds to Federal Funding Crisis with $8 Million Gift from Big Nova Foundation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNeXRrQnlaT1owbmpONHpGTEplUXdfWVp0NVBKcjl3X0JLNXBSYmRSR0hIVkRLd2ptVW4tSVltUEZ1VlZYeFlUVVFleTlpUkc2MGpLZDkyTlEwSVhUWVc2LWR3U21oT244WXRSRFhnVWZIbWJXV2VBOGNFZDFNaE5Na0RlVU9lalZqd2pNOXdlVjJyUl9xMUp1U1cyYlZOSUZxS2hOOVBnZ0VqQW5ZZ0E?oc=5","date":"2025-09-05","type":"pipeline","source":"Pharmacy Times","summary":"Blood Cancer Awareness Month: Advocacy, Education, and Empowering Communities - Pharmacy Times","headline":"Blood Cancer Awareness Month: Advocacy, Education, and Empowering Communities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOWEo5MUtYZkNjV0pQd3VBLWFDVXoxOENhVWtNNUlqYjA5M3ZvX2ZUNEZIdGVxbVp4U3NHSWVobFBpNkFjckEydEQzdjgzbU9wNHpJZFlkMUFlX01XMjlreG5VeE53ZGIyMnlKTDBpMGJJcjhONktGSFJURXd3QmR2U0kwdDdOaDlmNnpWTzdFWWtMc1Y1aWdFRXh6bnFSbHU2bDdEWGp4aWRKZ1lyWllJejlsYw?oc=5","date":"2025-08-28","type":"pipeline","source":"Fierce Pharma","summary":"Leukemia & Lymphoma Society rebrands, launches first national campaign in a decade - Fierce Pharma","headline":"Leukemia & Lymphoma Society rebrands, launches first national campaign in a decade","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}